Nephros (NEPH) Q3 2026 earnings review
Nephros profit rises on emergency orders, while routine reorders slow
Nephros, a maker of water filters for hospitals and commercial buildings, relied on one-off emergency orders this quarter as routine filter replacements slowed. Total revenue rose 18% from a year ago to $5.6 million, and net income grew 52% because management kept hiring and overhead expenses in check. However, chief executive Robert Banks had no one-time tariff refund to lift profitability this quarter, so gross margin slipped to 58%.
| Core programmatic sales growth | +8% down from +27% last quarter |
|---|---|
| Total net revenue | $5.6M +18% from a year ago |
| Gross margin | 58% 61% a year ago |
| Active customer sites | 1,766 +31 sites in the quarter |
⚖️ Verdict: 🔴 Bearish
The story got worse because core programmatic sales — scheduled filter reorders that management calls its best gauge of business health — grew just 8%, down from 27% in the second quarter. In addition, a 53% rise in inventory since December has drained cash even while the business reports a profit. On the positive side, the customer base reached a record 1,766 active locations, with over a third of new sites coming outside hospitals.
The question now is whether the slowdown in routine filter replacements is a one-quarter order delay or the result of higher customer turnover in commercial buildings. If hospital buyers simply shifted orders between quarters, programmatic growth will rebound above 15%; if commercial buyers are churning, reorder growth will stay in the single digits. Fourth-quarter programmatic revenue will tell.
🐂 Bull Case
Slower Hiring Lifted Operating Profit
Nephros makes water filters for hospitals and commercial buildings, and it has been hiring sales staff to enter new markets. In the third quarter, revenue grew 18% from a year ago to $5.6 million, outpacing those overhead additions. Selling, general and administrative expenses — the cost of sales staff, management and professional fees — rose 8.8% to $2.4 million, falling by 3.7 percentage points of revenue.
Research and development spending also fell by 1.2 percentage points of revenue to $331,000. That cost restraint more than offset a drop in gross margin, lifting operating margin by 2.3 percentage points to 8.9% and pushing net income up 52% to $512,000. The water filter maker showed it can grow profit even when import tariffs and shipping costs hurt product margins.
What to watch: selling, general and administrative expenses as a share of revenue in the fourth quarter. A reading near 43% would confirm that existing sales staff can handle higher volume without another wave of hiring.
Customer Base Reached a Record Beyond Hospitals
Nephros relies on its active installed base — customer locations that have ordered within the past twelve months — to generate repeat filter sales. Chief executive Robert Banks said the group added 31 new customer sites this quarter, lifting the active total to a record 1,766 locations. By our math, that follows 59 site additions in the second quarter and brings growth since December to 5.1%.
Hospitals and medical clinics remain the core business and supplied 64% of the quarter's new locations, Banks said. Commercial and industrial buildings contributed 17%, while government, military, hospitality and retail buyers made up the remaining 19%. Winning over a third of new sites outside hospitals matters because commercial water filtration is a larger market, even though those buyers replace filters less predictably.
What to watch: net new customer sites and the commercial share in the fourth-quarter report. Adding more than 30 sites while keeping commercial additions above a third would show the non-hospital expansion is holding its pace.
🐻 Bear Case
Routine Filter Reorders Slowed Sharply
"The third quarter of 2026 continued the strong momentum we have built across Nephros," chief executive Robert Banks said. In earlier quarters, Banks pointed to core programmatic revenue — scheduled filter replacements by existing customers — as the clearest gauge of business health because emergency orders after water contamination outbreaks are unpredictable.
This quarter, that routine replacement business slowed while one-off emergency orders carried the top line. Nephros said its 18% revenue growth came from programmatic sales and "significant growth in emergency response revenue".
- Core programmatic revenue growth: 8% from a year ago, down from 27% in the second quarter and 23% in the first quarter
- Total net revenue: $5.6 million, down 6.6% from the second quarter's $6.0 million record by our math
- Active customer sites: up 5.1% since December to 1,766 locations by our math
When programmatic growth drops from above 20% to 8% in three months, the headline 18% expansion rests on outbreak response that may not repeat. Commercial sites also have higher customer turnover than regulated hospitals, which can weaken reorder rates.
What to watch: core programmatic revenue growth in the fourth quarter. A second reading in the single digits would show that routine filter reorders have settled at a much slower pace.
Tariffs and Services Keep Gross Margin Below 60%
Nephros imports filter components from Italy and aims to keep gross margin above 60%. Last quarter, reported gross margin reached 67% only because the US company recorded a $0.6 million refund for invalidated import tariffs paid between April 2025 and February 2026. Without that one-time credit, second-quarter gross margin was 56.9% by our math.
In the third quarter, with no new refund benefit, gross margin fell 2.7 percentage points from a year ago to 58.4%, as cost of goods sold rose 2.7 percentage points of revenue. The filter maker blamed "higher inventory shipping and handling costs, including tariff expense, and growth in service revenue, which yields lower gross margins than product sales". Stripping the $0.6 million refund from nine-month results puts underlying gross margin at 57.6% by our math, proving that lower 10% tariff rates have not restored its old 60%-plus profitability.
What to watch: fourth-quarter gross margin. A reading below 60% would show that service growth and commercial product mix permanently offset lower tariff rates.
Inventory Build Consumes Cash Despite Profit
Nephros carries no debt and earned $1.8 million in net income over the first nine months of 2026. Yet its cash balance fell by $854,000 since December to $4.5 million at the end of September, and dropped by $151,000 during the third quarter alone by our math. The press release did not include a cash flow statement.
The balance sheet shows where the cash went: inventory rose 53.3% since December to nearly $5.0 million, adding another $406,000 in the third quarter, while nine-month sales grew 20%. Stocking up on filters ties up cash and increases the risk of future write-offs if routine programmatic orders continue to slow.
What to watch: inventory and cash balances in the quarterly filing and fourth-quarter release. A further rise in inventory above $5.0 million while sales grow below 20% would keep cash generation below reported net income.
👓 Other Themes
Water Institute Webinars Aim to Build Commercial Demand
Unlike hospitals, commercial buildings face few government rules requiring water filters. To create demand, Nephros runs free online classes through its Nephros Water Institute, which chief executive Robert Banks called "an important third pillar of our business alongside products and service". Banks plans to increase spending on these webinars to generate sales leads, though the classes bring in no direct revenue today.
💲 Other KPIs
Service and royalty revenue — fees for installing and replacing filters at customer sites — rose 13.7% from a year ago to $191,000. That slowed from 192.6% growth in the second quarter, when sales reached $316,000, by our math. Over the first nine months, service sales rose 51.9% to $679,000, which carries a lower gross margin than filter sales.
Uncollected customer bills and expected refunds fell 12.5% from last quarter's $4.10 million to $3.58 million by our math, helping slow the company's cash drain. Even so, the balance remains up 48.4% from $2.41 million at the end of December, partly because the water filter maker recorded a $0.6 million government tariff refund claim in the second quarter.
Diluted common shares rose 1.5% from a year ago to 11.20 million, up slightly from 11.11 million in the second quarter and 10.99 million in the first quarter. Nephros pays part of employee compensation in stock — $60,000 in the third quarter — and does not repurchase shares, creating modest dilution for shareholders.
❓ Key Questions
Why did routine filter replacement growth drop to 8%?
Core programmatic revenue grew 23% in the first quarter and 27% in the second quarter, then slowed to 8% in the third. Investors need to know if hospital customers delayed reorders or if newer commercial accounts are churning faster.
How much did emergency outbreak orders add to third-quarter sales?
Total revenue grew 18% while core programmatic revenue grew only 8%. Management cited significant growth in emergency response sales, which are unpredictable one-off orders following water contamination events, but did not disclose the dollar amount.
Has the US government paid the $0.6 million tariff refund?
Nephros booked a $0.6 million tariff refund claim in the second quarter as a receivable. Accounts receivable fell by $513,000 in the third quarter, yet cash still declined because inventory rose by $406,000.
Why is inventory up 53% this year against 20% sales growth?
Inventory reached $4.95 million in September, up from $3.23 million in December. Management needs to explain whether it is stockpiling Italian filter parts ahead of potential tariff changes or holding unsold commercial stock.